A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
Clinical trial NCT04677504 · COMPLETED
Trial details
- NCT number
- NCT04677504
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2022-05-16
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.